On behalf of Goethel Engelhardt, PLLC | Oct 31, 2012 | Fungal Meningitis
Criminal investigators from the Food and Drug Administration were at the New England Compounding Center in Framingham, Mass., on Tuesday, officials said, in the first public indication that the federal government was preparing a case against the company linked to a...
On behalf of Goethel Engelhardt, PLLC | Oct 31, 2012 | Fungal Meningitis
A Wayne County woman who lived in an extended care facility is among two new cases of deaths related to the fungal meningitis outbreak. The woman, 64, died Oct. 26, said Mary Mazur, spokeswoman for the Wayne County Department of Public Health. The Michigan Department...
On behalf of Goethel Engelhardt, PLLC | Oct 31, 2012 | Fungal Meningitis
A sister company of the compounding pharmacy at the heart of the fungal meningitis outbreak that has now claimed 29 lives is voluntarily recalling all its products. The move is an “expansion of our cooperation” with the FDA and the Massachusetts Board of...
On behalf of Goethel Engelhardt, PLLC | Oct 31, 2012 | Fungal Meningitis
The Indiana Attorney General’s Office confirms they filed a petition today to suspend the license of the Massachusetts specialty pharmacy linked to a nationwide outbreak of fungal meningitis. The office is asking the state pharmacy board to prohibit the New...
On behalf of Goethel Engelhardt, PLLC | Oct 31, 2012 | Fungal Meningitis
Shortly before a national fungal meningitis outbreak was linked to New England Compounding Center, the Framingham company sent customers a “Quality Assurance Report Card” trumpeting the cleanliness of its labs, even as internal tests showed widespread...
On behalf of Goethel Engelhardt, PLLC | Oct 31, 2012 | Medical/Health Care Errors
October 30, 2012 Three more people — two in Michigan and one in Tennessee — have died of fungal meningitis, the CDC reported Tuesday. The tally in the outbreak, linked to spinal injections of a contaminated steroid, now stands at 356 cases of the...
On behalf of Goethel Engelhardt, PLLC | Oct 31, 2012 | Fungal Meningitis
When a brand-name drug to help prevent premature births was approved last year, its $1,500-a-dose-price alarmed state and private sector insurance officials. Many restricted use of the FDA-approved Makena in favor of $20- to $40-a-dose versions that had been made for...
On behalf of Goethel Engelhardt, PLLC | Oct 31, 2012 | Medical/Health Care Errors
CASES WITH FUNGAL INFECTIONS LINKED TO STEROID INJECTIONS
On behalf of Goethel Engelhardt, PLLC | Oct 31, 2012 | Fungal Meningitis
October 17, 2012 Was it some moldy ceiling tiles? The dusty shoes of a careless employee? Or did the contamination of steroid injections tied to a nationwide fungal meningitis outbreak ride in on one of the ingredients? There are lots of ways fungus could have gotten...
On behalf of Goethel Engelhardt, PLLC | Oct 31, 2012 | Fungal Meningitis
FOR IMMEDIATE RELEASE – October 31, 2012 – Ameridose today announced it will commence a voluntary recall of any unexpired products remaining in circulation. This action is voluntary, and represents an expansion of our cooperation with the U.S.Food and Drug...
